Ascentage Pharma Group International Income Statement

Income Statement Dec2022 Dec2023 Dec2024
Revenue 0.03B0.03B0.14B
Cost of Revenue 0.02B0.03B0.03B
Gross Profit 0.03B0.03B0.13B
Research & Development 0.11B0.10B0.13B
Selling, General & Administrative -170.59B-181.08B-25.64B
Other Operating Expenses 170.49B180.98B25.51B
Operating Expenses 0.00B0.00B0.00B
Operating Income 0.03B0.03B0.13B
Interest & Investment Income -0.00B-0.01B
Other Non Operating Income 0.00B0.00B0.00B
EBIT 0.03B0.03B0.13B
EBT -0.13B-0.13B-0.06B
Tax Provisions -0.00B-0.00B0.00B
Profit After Tax -0.13B-0.13B-0.06B
Equity Income -0.00B0.00B-0.00B
Income from Non-Controlling Interests -0.00B-0.00B
Income from Continuing Operations -0.13B-0.13B-0.06B
Consolidated Net Income -0.13B-0.13B-0.06B
Income towards Parent Company -0.13B-0.13B-0.06B
Net Income towards Common Stockholders -0.13B-0.13B-0.06B
EPS (Basic) -0.50-0.46-0.18
EPS (Weighted Average and Diluted) -0.50-0.46-0.19
Shares Outstanding (Weighted Average) 0.31B0.31B
EBITDA 0.03B0.03B0.13B
Interest Expenses 0.01B0.01B0.01B
Tax Rate 0.48%0.77%